US Business
AstraZeneca Earnings Hit By Higher Costs
AstraZeneca reported core earnings for the fourth quarter just short of consensus, but said it expected double-digit percentage growth in 2024.
Copyright © 2023 Joplin Area Chamber of Commerce | Web Development by Storm Cloud Marketing